CVRx stock ticks up on Street-beating Q2 sales, raised guidance
CVRx shares were up this morning on second-quarter results that beat the consensus revenue forecast.
Source: massdevice.com
📰 Massdevice Medtech News
Page 29 - Massdevice Medtech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Massdevice Medtech. Real-time updates on events, politics, business and more.
Smith+Nephew stock dives on Q2 results, lowered 2022 guidance
Smith+Nephew (NYSE:SNN) shares took a hit today as the company revealed in its second-quarter earnings that it lowered its 2022 forecast.
Source: massdevice.com
Dexcom stock dips in Q2, broader G7 launch 'in coming weeks'
Dexcom (Nasdaq:DXCM) shares took a hit after hours today on second-quarter results that came up shy of the consensus forecast.
Source: massdevice.com
Integer boosts 2022 revenue projections, cuts earnings outlook
Integer posted second-quarter results this week that beat the overall revenue and earnings consensus forecast on Wall Street.
Source: massdevice.com
Conmed stock dips on lowered guidance despite Street-beating Q2
Conmed shares are down today on lowered 2022 guidance, even as its Q2 results beat Wall Street expectations.
Source: massdevice.com
Integra dips despite Street-beating Q2
Integra will sell its traditional wound care business to Gentell for up to $28.8 million. The expected close is around the end of August.
Source: massdevice.com
GE HealthCare slightly lowers expectations following Q2 results
GE shares were up on second-quarter results that came in ahead of the consensus forecast on Wall Street.
Source: massdevice.com
Stryker stock rises after hours despite missing Street projections in Q2
Stryker (NYSE:SYK) shares ticked up after the market closed on second-quarter results that came up shy of the consensus forecast.
Source: massdevice.com
Danaher rises on Street-beating Q2
Danaher shares got a boost today on second-quarter results that came in well ahead of the consensus forecast.
Source: massdevice.com
Abbott posts Street-beating Q2, raises 2022 guidance
Abbott shares were down before hours despite second-quarter results that topped the consensus forecast.
Source: massdevice.com